Eagle Pharmaceuticals Inc
EGRX
Market Cap$58.18M
Close$
$12.59
196.9% upside
Current Fair Value
196.9% upsideUndervalued by 196.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $58.18 Million |
|---|---|
| Enterprise Value | $113.02 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $0.9 |
| Beta | 0.62 |
| Outstanding Shares | 12,986,971 |
| Avg 30 Day Volume | 160,055 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 4.87 |
|---|---|
| PEG | -3.15 |
| Price to Sales | 0.22 |
| Price to Book Ratio | 0.22 |
| Enterprise Value to Revenue | 0.44 |
| Enterprise Value to EBIT | 2.76 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.62 |
| Debt to Equity | 0.28 |
Revenue Sources
No data
ESG Score
No data
About Eagle Pharmaceuticals Inc
CEO: Scott Tarriff